Document:

NEITHER
      THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
      BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
      COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
      THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
      MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
      STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
      OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
      SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS
      EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE
      SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY
      AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN
      CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH
      SECURITIES.

    

    Series
      C-2 Warrant Certificate No. 1

    

    SERIES
      C-2 COMMON STOCK PURCHASE WARRANT

    

    To
      Purchase ________ Shares of Common Stock of

     

    OMNIRELIANT
      HOLDINGS, INC.

     

    THIS
      SERIES C-2 COMMON STOCK PURCHASE WARRANT (the “Warrant”)
      certifies that, for value received, _________-- (the “Holder”),
      is
      entitled, upon the terms and subject to the limitations on exercise and the
      conditions hereinafter set forth, at any time on or after the date hereof (the
      “Initial
      Exercise Date”)
      and on
      or prior to the close of business on the tenth (10th) anniversary of the Initial
      Exercise Date (the “Termination
      Date”)
      but
      not thereafter, to subscribe for and purchase from OMNIRELIANT HOLDINGS, INC.,
      a
      Nevada corporation (the “Company”),
      up to
      _________ shares (the “Warrant
      Shares”)
      of
      Common Stock, par value $.00001 per share, of the Company (the “Common
      Stock”).
      The
      purchase price of one share of Common Stock under this Warrant shall be equal
      to
      the Exercise Price, as defined in Section
      2(b).
      

     

    Section
      1. Definitions.
      Capitalized terms used and not otherwise defined herein shall have the meanings
      set forth in that certain Securities Purchase Agreement (the “Purchase
      Agreement”),
      dated
      October 18, 2007, among the Company and the Holder.

     

    Section
      2. Exercise.

     

    
      
         

      

      
        Page
          1 of 15

        
          

        

      

      
         

      

    

     

    a)    Exercise
      of Warrant.
      Exercise of the purchase rights represented by this Warrant may be made, in
      whole or in part, at any time or times on or after the Initial Exercise Date
      and
      on or before the Termination Date by delivery to the Company of a duly executed
      facsimile copy of the Notice of Exercise form annexed hereto (or such other
      office or agency of the Company as it may designate by notice in writing to
      the
      registered Holder at the address of such Holder appearing on the books of the
      Company); and, within three (3) Trading Days of the date said Notice of Exercise
      is delivered to the Company, the Company shall have received payment of the
      aggregate Exercise Price of the shares thereby purchased by wire transfer or
      cashier’s check drawn on a United States bank. Notwithstanding anything herein
      to the contrary, the Holder shall not be required to physically surrender this
      Warrant to the Company until the Holder has purchased all of the Warrant Shares
      available hereunder and the Warrant has been exercised in full, in which case,
      the Holder shall surrender this Warrant to the Company for cancellation within
      three (3) Trading Days of the date the final Notice of Exercise is delivered
      to
      the Company. Partial exercises of this Warrant resulting in purchases of a
      portion of the total number of Warrant Shares available hereunder shall have
      the
      effect of lowering the outstanding number of Warrant Shares purchasable
      hereunder in an amount equal to the applicable number of Warrant Shares
      purchased. The Holder and the Company shall maintain records showing the number
      of Warrant Shares purchased and the date of such purchases. The Company shall
      deliver any objection to any Notice of Exercise within two (2) Trading Days
      of
      receipt of such notice. THE
      HOLDER AND ANY ASSIGNEE, BY ACCEPTANCE OF THIS WARRANT, ACKNOWLEDGE AND AGREE
      THAT, BY REASON OF THE PROVISIONS OF THIS PARAGRAPH, FOLLOWING THE PURCHASE
      OF A
      PORTION OF THE WARRANT SHARES HEREUNDER, THE NUMBER OF WARRANT SHARES AVAILABLE
      FOR PURCHASE HEREUNDER AT ANY GIVEN TIME MAY BE LESS THAN THE AMOUNT STATED
      ON
      THE FACE HEREOF.

     

    b)    Exercise
      Price.
      The
      exercise price per share of the Common Stock under this Warrant shall be $2.00,
      subject to adjustment hereunder (the “Exercise
      Price”).

     

    c)    Exercise
      Limitations.
      

     

    i. Holder’s
      Restrictions.
      The
      Company shall not effect any exercise of this Warrant, and a Holder shall not
      have the right to exercise any portion of this Warrant, pursuant to Section
      2
      or
      otherwise, to the extent that after giving effect to such issuance after
      exercise as set forth on the applicable Notice of Exercise, such Holder
      (together with such Holder’s Affiliates, and any other person or entity acting
      as a group together with such Holder or any of such Holder’s Affiliates), as set
      forth on the applicable Notice of Exercise, would beneficially own in excess
      of
      the Beneficial Ownership Limitation (as defined below).  For purposes of
      the foregoing sentence, the number of shares of Common Stock beneficially owned
      by such Holder and its Affiliates shall include the number of shares of Common
      Stock issuable upon exercise of this Warrant with respect to which such
      determination is being made, but shall exclude the number of shares of Common
      Stock which would be issuable upon (A) exercise of the remaining, nonexercised
      portion of this Warrant beneficially owned by such Holder or any of its
      Affiliates and (B) exercise or conversion of the unexercised or nonconverted
      portion of any other securities of the Company (including, without limitation,
      any other Series A Preferred Stock or Warrants) subject to a limitation on
      conversion or exercise analogous to the limitation contained herein beneficially
      owned by such Holder or any of its Affiliates.  Except as set forth in the
      preceding sentence, for purposes of this Section
      2(c)(i),
      beneficial ownership shall be calculated in accordance with Section 13(d) of
      the
      Exchange Act and the rules and regulations promulgated thereunder, it being
      acknowledged by a Holder that the Company is not representing to such Holder
      that such calculation is in compliance with Section 13(d) of the Exchange Act
      and such Holder is solely responsible for any schedules required to be filed
      in
      accordance therewith. To the extent that the limitation contained in this
Section
      2(c)(i)
      applies,
      the determination of whether this Warrant is exercisable (in relation to other
      securities owned by such Holder together with any Affiliates) and of which
      a
      portion of this Warrant is exercisable shall be in the sole discretion of a
      Holder, and the submission of a Notice of Exercise shall be deemed to be each
      Holder’s determination of whether this Warrant is exercisable (in relation to
      other securities owned by such Holder together with any Affiliates) and of
      which
      portion of this Warrant is exercisable, in each case subject to such aggregate
      percentage limitation, and the Company shall have no obligation to verify or
      confirm the accuracy of such determination. 

     

    
      
         

      

      
        Page
          2 of 15

        
          

        

      

      
         

      

    

    
In
      addition, a determination as to any group status as
      contemplated above shall be determined in accordance with Section 13(d) of
      the
      Exchange Act and the rules and regulations promulgated thereunder. For purposes
      of this Section
      2(c),
      in
      determining the number of outstanding shares of Common Stock, a Holder may
      rely
      on the number of outstanding shares of Common Stock as reflected in (X) the
      Company’s most recent Form 10-QSB or Form 10-KSB, as the case may be, (Y) a more
      recent public announcement by the Company or (Z) any other notice by the Company
      or the Company’s transfer agent setting forth the number of shares of Common
      Stock outstanding.  Upon the written or oral request of a Holder, the
      Company shall within two (2) Trading Days confirm orally and in writing to
      such
      Holder the number of shares of Common Stock then outstanding.  In any case,
      the number of outstanding shares of Common Stock shall be determined after
      giving effect to the conversion or exercise of securities of the Company,
      including this Warrant, by such Holder or its Affiliates since the date as
      of
      which such number of outstanding shares of Common Stock was reported. The
“Beneficial
      Ownership Limitation”
shall
      be 4.99% of the number of shares of the Common Stock outstanding immediately
      after giving effect to the issuance of shares of Common Stock issuable upon
      exercise of this Warrant. The Beneficial Ownership Limitation provisions of
      this
Section
      2(c)(i)
      may be
      waived by such Holder, at the election of such Holder, upon not less than 61
      days’ prior notice to the Company to change the Beneficial Ownership Limitation
      to 9.99% of the number of shares of the Common Stock outstanding immediately
      after giving effect to the issuance of shares of Common Stock upon exercise
      of
      this Warrant, and the provisions of this Section
      2(c)(i)
      shall
      continue to apply. Upon such a change by a Holder of the Beneficial Ownership
      Limitation from such 4.99% limitation to such 9.99% limitation, the Beneficial
      Ownership Limitation may not be further waived by such Holder. The provisions
      of
      this paragraph shall be construed and implemented in a manner otherwise than
      in
      strict conformity with the terms of this Section
      2(c)(i)
      to
      correct this paragraph (or any portion hereof) which may be defective or
      inconsistent with the intended Beneficial Ownership Limitation herein contained
      or to make changes or supplements necessary or desirable to properly give effect
      to such limitation. The limitations contained in this paragraph shall apply
      to a
      successor holder of this Warrant. Notwithstanding
      anything herein to the contrary, this provision shall not apply to any Holder
      that has elected to waive this provision on its signature page to the
      Securities Purchase Agreement, on or before the date of closing.

     

    d)    Mechanics
      of Exercise.
      

     

    i.
      Authorization
      of Warrant Shares.
      The
      Company covenants that all Warrant Shares which may be issued upon the exercise
      of the purchase rights represented by this Warrant will, upon exercise of the
      purchase rights represented by this Warrant, be duly authorized, validly issued,
      fully paid and nonassessable and free from all taxes, liens and charges created
      by the Company in respect of the issue thereof (other than taxes in respect
      of
      any transfer occurring contemporaneously with such issue). 

     

    ii.
      Delivery
      of Certificates Upon Exercise.
      Certificates for Warrant Shares purchased hereunder shall be transmitted by
      the
      transfer agent of the Company to the Holder by crediting the account of the
      Holder’s prime broker with the Depository Trust Company through its
      Deposit/Withdrawal at Custodian (“DWAC”)
      system
      if the Company is a participant in such system, and otherwise by delivery to
      the
      address specified by the Holder in the Notice of Exercise, within five (5)
      Trading Days from the delivery to the Company of the Notice of Exercise form,
      surrender of this Warrant (if required) and payment of the aggregate Exercise
      Price as set forth above (“Warrant
      Share Delivery Date”).
      This
      Warrant shall be deemed to have been exercised on the date the Exercise Price
      is
      received by the Company. The Warrant Shares shall be deemed to have been issued,
      and Holder or any other person so designated to be named therein shall be deemed
      to have become a holder of record of such shares for all purposes, as of the
      date the Warrant has been exercised by payment to the Company of the Exercise
      Price (or by cashless exercise, if permitted) and all taxes required to be
      paid
      by the Holder, if any, pursuant to Section
      2(d)(vii)
      prior to
      the issuance of such shares, have been paid. 

     

    
      
         

      

      
        Page
          3 of 15

        
          

        

      

      
         

      

    

     

    iii.
      Delivery
      of New Warrants Upon Exercise.
      If this
      Warrant shall have been exercised in part, the Company shall, at the request
      of
      a Holder and upon surrender of this Warrant certificate, at the time of delivery
      of the certificate or certificates representing Warrant Shares, deliver to
      Holder a new Warrant evidencing the rights of Holder to purchase the unpurchased
      Warrant Shares called for by this Warrant, which new Warrant shall in all other
      respects be identical with this Warrant.

     

    iv.
      Rescission
      Rights.
      If the
      Company fails to cause its transfer agent to transmit to the Holder a
      certificate or certificates representing the Warrant Shares pursuant to
Section
      2(d)(ii)
      above by
      the Warrant Share Delivery Date, then the Holder will have the right to rescind
      such exercise.

     

    v.
      Obligation
      Absolute; Damages.
      The
      Corporation’s obligations to issue and deliver the certificates representing the
      Warrant Shares upon exercise of the Warrant in accordance with the terms hereof
      are absolute and unconditional, irrespective of any action or inaction by the
      Holder to enforce the same, any waiver or consent with respect to any provision
      hereof, the recovery of any judgment against any Person or any action to enforce
      the same, or any setoff, counterclaim, recoupment, limitation or termination,
      or
      any breach or alleged breach by the Holder or any other Person of any obligation
      to the Corporation or any violation or alleged violation of law by the Holder
      or
      any other person, and irrespective of any other circumstance which might
      otherwise limit such obligation of the Corporation to the Holder in connection
      with the issuance of such certificates representing the Warrant Shares. The
      Corporation shall issue the certificates representing the Warrant Shares or,
      if
      applicable, cash, upon a properly noticed exercise. If the Corporation fails
      to
      deliver to the Holder such certificate or certificates pursuant to Section
      2(d)
      within
      five (5) Trading Days of the Warrant Share Delivery Date applicable to such
      exercise, the Corporation shall pay to such Holder, in cash, as liquidated
      damages and not as a penalty, for each $1,000 of VWAP of the Common Stock,
      $10
      per Trading Day (increasing to $20 per Trading Day after ten (10) Trading Days
      after the Warrant Share Delivery Date) for each Trading Day after the Warrant
      Share Delivery Date until such certificates are delivered. 

     

    vi.
      No
      Fractional Shares or Scrip.
      No
      fractional shares or scrip representing fractional shares shall be issued upon
      the exercise of this Warrant. As to any fraction of a share which Holder would
      otherwise be entitled to purchase upon such exercise, the Company shall at
      its
      election, either pay a cash adjustment in respect of such final fraction in
      an
      amount equal to such fraction multiplied by the Exercise Price or round up
      to
      the next whole share.

     

    
      
         

      

      
        Page
          4 of 15

        
          

        

      

      
         

      

    

     

    vii.
      Charges,
      Taxes and Expenses.
      Issuance of certificates for Warrant Shares shall be made without charge to
      the
      Holder or other incidental expense in respect of the issuance of such
      certificate, and such certificates shall be issued in the name of the Holder
      or
      in such name or names as may be directed by the Holder; provided,
      however,
      that in
      the event certificates for Warrant Shares are to be issued in a name other
      than
      the name of the Holder, this Warrant when surrendered for exercise shall be
      accompanied by the Assignment Form attached hereto duly executed by the Holder;
      the assignment shall be subject to Section
      4
      below,
      and the Company may require, as a condition thereto, the payment of a sum
      sufficient to reimburse it for any transfer tax incidental thereto.

     

    viii.
      Closing
      of Books.
      The
      Company will not close its stockholder books or records in any manner which
      prevents the timely exercise of this Warrant, pursuant to the terms
      hereof.

     

    e)    Cashless
      Exercise if no Registration Statement.
      If at
      any time after one year from the date of issuance of this Warrant there is
      no
      effective Registration Statement registering, or no current prospectus available
      for, the resale of the Warrant Shares by the Holder, then this Warrant may
      also
      be exercised at such time by means of a “cashless exercise” in which the Holder
      shall be entitled to receive a certificate for the number of Warrant Shares
      equal to the quotient obtained by dividing [(A-B) (X)] by (A),
      where:

     

    
      	
            	(A)
              =	
              the
                VWAP on the Trading Day immediately preceding the date of such
                election;

            

    

    

    
      	
            	(B)
              =	
              the
                Exercise Price of this Warrant, as adjusted; and
                

            

    

    

    
      	
            	(X)
              =	
              the
                number of Warrant Shares issuable upon exercise of this Warrant in
                accordance with the terms of this Warrant by means of a cash exercise
                rather than a cashless exercise.

            

    

    

    Section
      3. Certain
      Adjustments.

     

    a)    Stock
      Dividends and Splits.
      If the
      Company, at any time while this Warrant is outstanding: (i) pays a stock
      dividend or otherwise makes a distribution or distributions on shares of its
      Common Stock or any other equity or equity equivalent securities payable in
      shares of Common Stock (which, for avoidance of doubt, shall not include any
      shares of Common Stock issued by the Company upon exercise of this Warrant),
      provided that this clause (i) shall not apply to shares of Common Stock issued
      solely in connection with dividends required to be paid under the terms and
      conditions of the Series A Preferred Stock, provided that the terms of such
      Series A Preferred Stock shall not have been amended since the date of this
      Agreement, (ii) subdivides outstanding shares of Common Stock into a larger
      number of shares, (iii) combines (including by way of reverse stock split)
      outstanding shares of Common Stock into a smaller number of shares, or (iv)
      issues by reclassification of shares of the Common Stock any shares of capital
      stock of the Company, then in each case the Exercise Price shall be multiplied
      by a fraction of which the numerator shall be the number of shares of Common
      Stock (excluding treasury shares, if any) outstanding immediately before such
      event and of which the denominator shall be the number of shares of Common
      Stock
      outstanding immediately after such event and the number of shares issuable
      upon
      exercise of this Warrant shall be proportionately adjusted. Any adjustment
      made
      pursuant to this Section
      3(a)
      shall
      become effective immediately after the record date for the determination of
      stockholders entitled to receive such dividend or distribution and shall become
      effective immediately after the effective date in the case of a subdivision,
      combination or re-classification.

     

    
      
         

      

      
        Page
          5 of 15

        
          

        

      

      
         

      

    

     

    b)    Subsequent
      Equity Sales.
      If the
      Company or any Subsidiary thereof, as applicable, at any time while this Warrant
      is outstanding, sells, grants or otherwise issues (or announces any sale, grant
      or other issuance related to the foregoing) any Common Stock or Common Stock
      Equivalents entitling any Person to acquire shares of Common Stock, at an
      effective price per share less than the then Exercise Price (such lower price,
      the “Base
      Share Price”
and
      such issuances collectively, a “Dilutive
      Issuance”)
      (if
      the holder of the Common Stock or Common Stock Equivalents so issued shall
      at
      any time, whether by operation of purchase price adjustments, reset provisions,
      floating conversion, exercise or exchange prices or otherwise, or due to
      warrants, options or rights per share which are issued in connection with such
      issuance, be entitled to receive shares of Common Stock at an effective price
      per share which is less than the Exercise Price, such issuance shall be deemed
      to have occurred for less than the Exercise Price on such date of the Dilutive
      Issuance), then the Exercise Price shall be reduced and only reduced to equal
      the Base Share Price, and the number of Warrant Shares issuable hereunder shall
      be increased such that the aggregate Exercise Price payable hereunder, after
      taking into account the decrease in the Exercise Price, shall be equal to the
      aggregate Exercise Price prior to such adjustment. Such adjustment to the
      Exercise Price shall be made whenever such Common Stock or Common Stock
      Equivalents are issued. Notwithstanding the foregoing, no adjustments shall
      be
      made, paid or issued under this Section
      3(b)
      in
      respect of an Exempt Issuance or issuances subject to Section
      3(a)
      above.
      The Company shall notify the Holder in writing, no later than the third
      (3rd)
      Trading
      Day following the issuance of any Common Stock or Common Stock Equivalents
      subject to this section, indicating therein the applicable issuance price,
      or
      applicable reset price, exchange price, conversion price and other pricing
      terms
      (such notice the “Dilutive
      Issuance Notice”).
      For
      purposes of clarification, whether or not the Company provides a Dilutive
      Issuance Notice pursuant to this Section
      3(b),
      upon
      the occurrence of any Dilutive Issuance, after the date of such Dilutive
      Issuance, the Holder is entitled to receive a number of Warrant Shares based
      upon the Base Share Price regardless of whether the Holder accurately refers
      to
      the Base Share Price in the Notice of Exercise.

     

    c)    Subsequent
      Rights Offerings.
      If the
      Company, at any time while this Warrant is outstanding, shall issue rights,
      options or warrants to all holders of Common Stock (and not to Holders)
      entitling them to subscribe for or purchase shares of Common Stock at a price
      per share less than the VWAP as of the record date mentioned below, then the
      Exercise Price shall be multiplied by a fraction, of which the denominator
      shall
      be the number of shares of the Common Stock outstanding on the date of issuance
      of such rights or warrants plus the number of additional shares of Common Stock
      offered for subscription or purchase, and of which the numerator shall be the
      number of shares of the Common Stock outstanding on the date of issuance of
      such
      rights, options or warrants plus the number of shares which the aggregate
      offering price of the total number of shares so offered (assuming receipt by
      the
      Company in full of all consideration payable upon exercise of such rights,
      options or warrants) would purchase at such VWAP. Such adjustment shall be
      made
      whenever such rights, options or warrants are issued, and shall become effective
      immediately after the record date for the determination of stockholders entitled
      to receive such rights, options or warrants. 

     

    
      
         

      

      
        Page
          6 of 15

        
          

        

      

      
         

      

    

     

    d)    Pro
      Rata Distributions.
      If the
      Company, at any time prior to the Termination Date, shall distribute to all
      holders of Common Stock (and not to Holders of the Warrants) evidences of its
      indebtedness or assets (including cash and cash dividends) or rights or warrants
      to subscribe for or purchase any security other than the Common Stock (which
      shall be subject to Section
      3(c)),
      then
      in each such case the Exercise Price shall be adjusted by multiplying the
      Exercise Price in effect immediately prior to the record date fixed for
      determination of stockholders entitled to receive such distribution by a
      fraction of which the denominator shall be the VWAP determined as of the record
      date mentioned above, and of which the numerator shall be such VWAP as of such
      record date less the then per share fair market value at such record date of
      the
      portion of such assets or evidence of indebtedness so distributed applicable
      to
      one outstanding share of the Common Stock as determined by the Board of
      Directors in good faith. In either case the adjustments shall be described
      in a
      statement provided to the Holder of the portion of assets or evidences of
      indebtedness so distributed or such subscription rights applicable to one share
      of Common Stock. Such adjustment shall be made whenever any such distribution
      is
      made and shall become effective immediately after the record date mentioned
      above.

     

    e    Fundamental
      Transaction.
      If, at
      any time while this Warrant is outstanding, (i) the Company effects any merger
      or consolidation of the Company with or into another Person, (ii) the Company
      effects any sale of all or substantially all of its assets in one or a series
      of
      related transactions, (iii) any tender offer or exchange offer (whether by
      the
      Company or another Person) is completed pursuant to which holders of Common
      Stock are permitted to tender or exchange their shares for other securities,
      cash or property, or (iv) the Company effects any reclassification of the Common
      Stock or any compulsory share exchange pursuant to which the Common Stock is
      effectively converted into or exchanged for other securities, cash or property
      (in any such case, a “Fundamental
      Transaction”),
      then,
      upon any subsequent exercise of this Warrant, the Holder shall have the right
      to
      receive, for each Warrant Share that would have been issuable upon such exercise
      immediately prior to the occurrence of such Fundamental Transaction, at the
      option of the Holder, (a) upon exercise of this Warrant, the number of shares
      of
      Common Stock of the successor or acquiring corporation or of the Company, if
      it
      is the surviving corporation, and any additional consideration (the
“Alternate
      Consideration”)
      receivable upon or as a result of such reorganization, reclassification, merger,
      consolidation or disposition of assets by a Holder of the number of shares
      of
      Common Stock for which this Warrant is exercisable immediately prior to such
      event or (b) if the Company is acquired in an all cash transaction, cash equal
      to the value of this Warrant as determined in accordance with the Black-Scholes
      option pricing formula. For purposes of any such exercise, the determination
      of
      the Exercise Price shall be appropriately adjusted to apply to such Alternate
      Consideration based on the amount of Alternate Consideration issuable in respect
      of one share of Common Stock in such Fundamental Transaction, and the Company
      shall apportion the Exercise Price among the Alternate Consideration in a
      reasonable manner reflecting the relative value of any different components
      of
      the Alternate Consideration. If holders of Common Stock are given any choice
      as
      to the securities, cash or property to be received in a Fundamental Transaction,
      then the Holder shall be given the same choice as to the Alternate Consideration
      it receives upon any exercise of this Warrant following such Fundamental
      Transaction. To the extent necessary to effectuate the foregoing provisions,
      any
      successor to the Company or surviving entity in such Fundamental Transaction
      shall issue to the Holder a new warrant consistent with the foregoing provisions
      and evidencing the Holder’s right to exercise such warrant into Alternate
      Consideration. The terms of any agreement pursuant to which a Fundamental
      Transaction is effected shall include terms requiring any such successor or
      surviving entity to comply with the provisions of this Section
      3(e)
      and
      insuring that this Warrant (or any such replacement security) will be similarly
      adjusted upon any subsequent transaction analogous to a Fundamental
      Transaction.

     

    
      
         

      

      
        Page
          7 of 15

        
          

        

      

      
         

      

    

     

    f)    Calculations.
      All
      calculations under this Section
      3
      shall be
      made to the nearest cent or the nearest 1/100th of a share, as the case may
      be.
      For purposes of this Section
      3,
      the
      number of shares of Common Stock deemed to be issued and outstanding as of
      a
      given date shall be the sum of the number of shares of Common Stock (excluding
      treasury shares, if any) issued and outstanding.

     

    g)    Voluntary
      Adjustment By Company.
      The
      Company may at any time during the term of this Warrant reduce the then current
      Exercise Price to any amount and for any period of time deemed appropriate
      by
      the Board of Directors of the Company.

     

    h)    Notice
      to Holders.
      

     

    i. Adjustment
      to Exercise Price.
      Whenever the Exercise Price is adjusted pursuant to any provision of this
Section
      3,
      the
      Company shall promptly mail to each Holder a notice setting forth the Exercise
      Price after such adjustment and setting forth a brief statement of the facts
      requiring such adjustment. 

     

    ii. Notice
      to Allow Exercise by Holder.
      If (A)
      the Company shall declare a dividend (or any other distribution in whatever
      form) on the Common Stock; (B) the Company shall declare a special nonrecurring
      cash dividend on or a redemption of the Common Stock; (C) the Company shall
      authorize the granting to all holders of the Common Stock rights or warrants
      to
      subscribe for or purchase any shares of capital stock of any class or of any
      rights; (D) the approval of any stockholders of the Company shall be required
      in
      connection with any reclassification of the Common Stock, any consolidation
      or
      merger to which the Company is a party, any sale or transfer of all or
      substantially all of the assets of the Company, of any compulsory share exchange
      whereby the Common Stock is converted into other securities, cash or property;
      (E) the Company shall authorize the voluntary or involuntary dissolution,
      liquidation or winding up of the affairs of the Company; then, in each case,
      the
      Company shall cause to be mailed to the Holder at its last address as it shall
      appear upon the Warrant Register of the Company, at least ten (10) calendar
      days
      prior to the applicable record or effective date hereinafter specified, a notice
      stating (X) the date on which a record is to be taken for the purpose of such
      dividend, distribution, redemption, rights or warrants, or if a record is not
      to
      be taken, the date as of which the holders of the Common Stock of record to
      be
      entitled to such dividend, distributions, redemption, rights or warrants are
      to
      be determined or (Y) the date on which such reclassification, consolidation,
      merger, sale, transfer or share exchange is expected to become effective or
      close, and the date as of which it is expected that holders of the Common Stock
      of record shall be entitled to exchange their shares of the Common Stock for
      securities, cash or other property deliverable upon such reclassification,
      consolidation, merger, sale, transfer or share exchange; provided that the
      failure to mail such notice or any defect therein or in the mailing thereof
      shall not affect the validity of the corporate action required to be specified
      in such notice. The Holder is entitled to exercise this Warrant during the
      ten
      (10) day period commencing on the date of such notice to the effective date
      of
      the event triggering such notice.

     

    
      
         

      

      
        Page
          8 of 15

        
          

        

      

      
         

      

    

     

    Section
      4. Transfer
      of Warrant.

     

    a)    Transferability.
      Subject
      to compliance with any applicable securities laws and the conditions set forth
      in Section
      4(d)
      hereof,
      this Warrant and all rights hereunder (including, without limitation, any
      registration rights) are transferable, in whole or in part, upon surrender
      of
      this Warrant at the principal office of the Company or its designated agent,
      together with a written assignment of this Warrant substantially in the form
      attached hereto duly executed by the Holder or its agent or attorney and funds
      sufficient to pay any transfer taxes payable upon the making of such transfer.
      Upon such surrender and, if required, such payment, the Company shall execute
      and deliver a new Warrant or Warrants in the name of the assignee or assignees
      and in the denomination or denominations specified in such instrument of
      assignment, and shall issue to the assignor a new Warrant evidencing the portion
      of this Warrant not so assigned, and this Warrant shall promptly be cancelled.
      A
      Warrant, if properly assigned, may be exercised by a new holder for the purchase
      of Warrant Shares without having a new Warrant issued. 

     

    b)    New
      Warrants.
      This
      Warrant may be divided or combined with other Warrants upon presentation hereof
      at the aforesaid office of the Company, together with a written notice
      specifying the names and denominations in which new Warrants are to be issued,
      signed by the Holder or its agent or attorney. Subject to compliance with
Section
      4(a),
      as to
      any transfer which may be involved in such division or combination, the Company
      shall execute and deliver a new Warrant or Warrants in exchange for the Warrant
      or Warrants to be divided or combined in accordance with such
      notice.

     

    c)    Warrant
      Register.
      The
      Company shall register this Warrant, upon records to be maintained by the
      Company for that purpose (the “Warrant
      Register”),
      in
      the name of the record Holder hereof from time to time. The Company may deem
      and
      treat the registered Holder of this Warrant as the absolute owner hereof for
      the
      purpose of any exercise hereof or any distribution to the Holder, and for all
      other purposes, absent actual notice
      to
      the contrary.

     

    
      
         

      

      
        Page
          9 of 15

        
          

        

      

      
         

      

    

     

    d)    Transfer
      Restrictions.
      If, at
      the time of the surrender of this Warrant
      in
      connection with any transfer of this Warrant,
      the
      transfer of this Warrant
      shall
      not
      be registered pursuant to an effective registration statement under the
Securities
      Act and
      under
      applicable state securities or blue sky laws, the Company
      may
      require, as a condition of allowing such transfer (i)
      that
      the
Holder
      or
      transferee of this Warrant,
      as the
      case may be, furnish to the Company
      a
      written
      opinion of counsel (which opinion shall be in form, substance and scope
      customary for opinions of counsel in comparable transactions) to the effect
      that
      such transfer may be made without registration under the Securities
      Act and
      under
      applicable state securities or blue sky laws, (ii)
      that
      the
holder
      or
      transferee execute and deliver to the Company
      an
      investment letter in form and substance acceptable to the Company
      and
      (iii)
      that
      the
      transferee be an “accredited investor” as defined in Rule 501(a)(1),
(a)(2),
      (a)(3),
      (a)(7),
      or
(a)(8)
      promulgated
      under the Securities
      Act or
      a
“qualified institutional buyer” as defined in Rule 144A(a) under the
Securities
      Act.

     

    Section
      5. Miscellaneous.

     

    a)    No
      Rights as Shareholder Until Exercise.
      This
      Warrant does not entitle the Holder to any voting rights or other rights as
      a
      shareholder of the Company prior to the exercise hereof as set forth in
Section
      2.
      

     

    b)    Loss,
      Theft, Destruction or Mutilation of Warrant.
      The
      Company covenants that upon receipt by the Company of evidence reasonably
      satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
      or any stock certificate relating to the Warrant Shares, and in case of loss,
      theft or destruction, of indemnity or security reasonably satisfactory to it
      (which, in the case of the Warrant, shall not include the posting of any bond),
      and upon surrender and cancellation of such Warrant or stock certificate, if
      mutilated, the Company will make and deliver a new Warrant or stock certificate
      of like tenor and dated as of such cancellation, in lieu of such Warrant or
      stock certificate.

     

    c)    Saturdays,
      Sundays, Holidays, etc.
      If the
      last or appointed day for the taking of any action or the expiration of any
      right required or granted herein shall not be a Business Day, then such action
      may be taken or such right may be exercised on the next succeeding Business
      Day.

     

    
      
         

      

      
        Page
          10 of
          15

        
          

        

      

      
         

      

    

     

    d)    Authorized
      Shares.
      The
      Company covenants that, during the period the Warrant is outstanding, it will
      reserve from its authorized and unissued Common Stock a sufficient number of
      shares to provide for the issuance of the Warrant Shares upon the exercise
      of
      any purchase rights under this Warrant. The Company further covenants that
      its
      issuance of this Warrant shall constitute full authority to its officers who
      are
      charged with the duty of executing stock certificates to execute and issue
      the
      necessary certificates for the Warrant Shares upon the exercise of the purchase
      rights under this Warrant. The Company will take all such reasonable action
      as
      may be necessary to assure that such Warrant Shares may be issued as provided
      herein without violation of any applicable law or regulation, or of any
      requirements of the Trading Market upon which the Common Stock may be listed.
      

     

    Before
      taking any action which would result in an adjustment in the number of Warrant
      Shares for which this Warrant is exercisable or in the Exercise Price, the
      Company shall obtain all such authorizations or exemptions thereof, or consents
      thereto, as may be necessary from any public regulatory body or bodies having
      jurisdiction thereof.

     

    e)    Jurisdiction.
      All
      questions concerning the construction, validity, enforcement, venue,
      jurisdiction, and interpretation of this Warrant shall be determined in
      accordance with the provisions of the Purchase Agreement.

     

    f)    Restrictions.
      The
      Holder acknowledges that the Warrant Shares acquired upon the exercise of this
      Warrant, if not registered, will have restrictions upon resale imposed by state
      and federal securities laws.

     

    g)    Nonwaiver
      and Expenses.
      No
      course of dealing or any delay or failure to exercise any right hereunder on
      the
      part of Holder shall operate as a waiver of such right or otherwise prejudice
      Holder’s rights, powers or remedies, notwithstanding the fact that all rights
      hereunder terminate on the Termination Date. If the Company willfully and
      knowingly fails to comply with any provision of this Warrant, which results
      in
      any material damages to the Holder, the Company shall pay to Holder such amounts
      as shall be sufficient to cover any costs and expenses including, but not
      limited to, reasonable attorneys’ fees, including those of appellate
      proceedings, incurred by Holder in collecting any amounts due pursuant hereto
      or
      in otherwise enforcing any of its rights, powers or remedies
      hereunder.

     

    h)    Notices.
      Any
      notice, request or other document required or permitted to be given or delivered
      to the Holder by the Company shall be delivered in accordance with the notice
      provisions of the Purchase Agreement.

     

    i)    Limitation
      of Liability.
      No
      provision hereof, in the absence of any affirmative action by Holder to exercise
      this Warrant to purchase Warrant Shares, and no enumeration herein of the rights
      or privileges of Holder, shall give rise to any liability of Holder for the
      purchase price of any Common Stock or as a stockholder of the Company, whether
      such liability is asserted by the Company or by creditors of the
      Company.

     

    
      
         

      

      
        Page
          11 of
          15

        
          

        

      

      
         

      

    

     

    j)    Remedies.
      Holder,
      in addition to being entitled to exercise all rights granted by law, including
      recovery of damages, will be entitled to specific performance of its rights
      under this Warrant. The Company agrees that monetary damages would not be
      adequate compensation for any loss incurred by reason of a breach by it of
      the
      provisions of this Warrant and hereby agrees to waive and not to assert the
      defense in any action for specific performance that a remedy at law would be
      adequate.

     

    k)    Successors
      and Assigns.
      Subject
      to applicable securities laws, this Warrant and the rights and obligations
      evidenced hereby shall inure to the benefit of and be binding upon the
      successors of the Company and the successors and permitted assigns of Holder.
      The provisions of this Warrant are intended to be for the benefit of all Holders
      from time to time of this Warrant and shall be enforceable by any such Holder
      or
      holder of Warrant Shares.

     

    l)    Amendment.
      This
      Warrant may be modified or amended or the provisions hereof waived only with
      the
      written consent of the Company and the Holder.

     

    m)    Severability.
      Wherever possible, each provision of this Warrant shall be interpreted in such
      manner as to be effective and valid under applicable law, but if any provision
      of this Warrant shall be prohibited by or invalid under applicable law, such
      provision shall be ineffective to the extent of such prohibition or invalidity,
      without invalidating the remainder of such provisions or the remaining
      provisions of this Warrant.

     

    n)    Headings.
      The
      headings used in this Warrant are for the convenience of reference only and
      shall not, for any purpose, be deemed a part of this Warrant.

     

    

    ********************

     

    
      
         

      

      
        Page
          12 of
          15

        
          

        

      

      
         

      

    

    

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be executed by its
      officer thereunto duly authorized.

    

    Dated:
      October __, 2007

     

    
      	 	 	 
	 	OMNIRELIANT
              HOLDINGS, INC.
	 
 	 
 	 
 
	 	By:  	 
	 	
              
Name:
              Christopher Phillips
	 	
              Title: Chief
                Executive Officer

            

    

     

    
      
         

      

      
        Page
          13 of
          15

        
          

        

      

      
         

      

    

     

    NOTICE
      OF EXERCISE

    

    TO:    OMNIRELIANT
      HOLDINGS, INC. (THE “COMPANY”)

    

    (1) The
      undersigned hereby elects to purchase ________ Warrant Shares of the Company
      pursuant to the terms of the attached Warrant (only if exercised in full),
      and
      tenders herewith payment of the exercise price in full, together with all
      applicable transfer taxes, if any.

     

    (2) Payment
      will be made in lawful money of the United States.

     

    (3) Please
      issue a certificate or certificates representing said Warrant Shares in the
      name
      of the undersigned or in such other name as is specified below:

     

    _______________________________

    

     

    The
      Warrant Shares shall be delivered to the following DWAC Account Number or by
      physical delivery of a certificate to:

    

    _______________________________

     

    _______________________________

     

    _______________________________

    

    (4)
      Accredited
      Investor.
      The
      undersigned certifies that it is an “accredited investor” as defined in
      Regulation D promulgated under the Securities Act of 1933, as
      amended.

    

    [SIGNATURE
      OF HOLDER]

     

    Name
      of
      Investing
      Entity:__________________________________________________________________

    Signature
      of Authorized Signatory of Investing Entity:____________________________________________

    Name
      of
      Authorized
      Signatory:______________________________________________________________

    Title
      of
      Authorized
      Signatory:_______________________________________________________________

    Date:__________________________________________________________________________________

     

    
      
         

      

      
        Page
          14 of
          15

        
          

        

      

      
         

      

    

     

    ASSIGNMENT
      FORM

    

    (To
      assign the foregoing warrant, execute

    this
      form
      and supply required information. 

    Do
      not
      use this form to exercise the warrant.)

    

    FOR
      VALUE
      RECEIVED, _________ shares of the foregoing Warrant and all rights evidenced
      thereby are hereby assigned to _________________________________whose address
      is
      ____________________________________________________________________________________________________________________________.

    
 

    
      	 	 	Dated: ______________, _______
	 	 	 
	 	
              Holder’s
                Signature:_________________________

               

              Holder’s Address:__________________________

               

                                              
                __________________________

            	 

    

    

    Signature
      Guaranteed: ___________________________________________

    

    

    NOTE:
      The
      signature to this Assignment Form must correspond with the name as it appears
      on
      the face of the Warrant, without alteration or enlargement or any change
      whatsoever, and must be guaranteed by a bank or trust company. Officers of
      corporations and those acting in a fiduciary or other representative capacity
      should file proper evidence of authority to assign the foregoing
      Warrant.

     

    
      
         

      

      
        Page
          15 of
          15Exhibit
      10.1    

     

    FIRST
      AMENDMENT 

    TO

    LOAN
      AGREEMENT

     

    This
      First Amendment to Loan Agreement is entered into as of October 18, 2007 (the
      “Amendment”), by and between AGILITY CAPITAL, LLC (“Agility”) and NORTH AMERICAN
      SCIENTIFIC, INC. (“Borrower”).

     

    RECITALS

     

    Borrower
      and Agility are parties to that certain Loan Agreement dated as of September
      21,
      2007 (the “Agreement”). The parties desire to amend the Agreement in accordance
      with the terms of this Amendment. 

     

    Now,
      Therefore,
      the
      parties agree as follows:

     

    1. Total
      Credit Amount       
       Total Credit Amount is increased to $1,000,000.

     

    2. Advances
      and Payments. 
       Section 1 (a) Advances
      is
      hereby modified in full as follows:

     

    
      	 	
              (a)

            	
              Advances.
                Borrower may request one or more advances (each, an “Advance” and
                collectively, the “Advances”) on a revolving basis, up to the following
                maximum outstanding amounts: 

            

    

     

    
      	 	
              (i)

            	
              Advance
                in the principal amount of up to $500,000 upon the execution of all
                original loan documents.

            

    

     

    
      	 	
              (ii)

            	
              Advance
                of up to $500,000 upon the completion of this First Amendment to
                Loan
                Agreement.

            

    

     

    3. On
      the
      date hereof, Borrower shall deliver a Warrant to Purchase Stock to Lender in
      substantially the form attached, in exchange for Lender’s returning to Borrower
      the Warrant to Purchase Stock dated September 21, 2007.

     

    4. Notwithstanding
      anything to the contrary in the Agreement, Agility hereby consents to the
      Borrower incurring up to $500,000 of subordinated unsecured indebtedness to
      John
      Friede or an entity owned or controlled by him (“Friede”), provided that Friede
      executes and delivers to Agility, on
      Agility’s standard form with such changes thereto as are acceptable to Agility
      in its good faith business judgment, a subordination agreement pursuant
      to which the debt owed by Borrower to Friede will be subordinated to the debt
      owed to Agility.

     

    5. Unless
      otherwise defined, all initially capitalized terms in this Amendment shall
      be as
      defined in the Agreement. The Agreement, as amended hereby, shall be and remain
      in full force and effect in accordance with its respective terms and hereby
      is
      ratified and confirmed in all respects. Except as expressly set forth herein,
      the execution, delivery, and performance of this Amendment shall not operate
      as
      a waiver of, or as an amendment of, any right, power, or remedy of Agility
      under
      the Agreement, as in effect prior to the date hereof. Borrower ratifies and
      reaffirms the continuing effectiveness of all instruments, documents and
      agreements entered into in connection with the Agreement.

     

    
      
         

      

      
        1

        
          

        

      

      
         

      

    

    6. Borrower
      represents and warrants that the representations and warranties contained in
      the
      Agreement are true and correct as of the date of this Amendment, and that no
      Event of Default has occurred and is continuing.

     

    7. This
      Amendment may be executed in two or more counterparts, each of which shall
      be
      deemed an original, but all of which together shall constitute one
      instrument.

     

    8. As
      a
      condition to the effectiveness of this Amendment, Agility shall have received,
      in form and substance satisfactory to Agility, the following:

     

    
      	 	
              a.

            	
              this
                Amendment, duly executed by
                Borrower;

            

    

     

    
      	 	
              b.

            	
              a
                Warrant to Purchase Stock in substantially the form
                attached;

            

    

     

    
      	 	
              c.

            	
              Corporate
                Resolutions to Borrow;

            

    

     

    
      	
            	d.	
              payment
                of a loan modification and extension fee of $10,000, due and payable
                on
                execution of this agreement; and

            

    

     

    
      	
            	e.	
              such
                other documents, and completion of such other matters, as Agility
                may
                reasonably deem necessary or
                appropriate.

            

    

     

    In
      Witness Whereof,
      the
      undersigned have executed this Amendment as of the first date above
      written.

     

    
      
        	 	
                NORTH
                  AMERICAN SCIENTIFIC, INC.

              
	 	 
	 	
                By:
                  /s/James W.
                  Klingler                                                                    
                  

              
	 	
                Title:
                  Sr. V.P. & Chief Financial
                  Officer                                             

              
	 	 
	 	 
	 	
                AGILITY
                  CAPITAL, LLC

              
	 	 
	 	
                By:
                  /s/Daniel
                  Corry                                                                              
                  

              
	 	
                Title:
                  Chief Credit
                  Officer                                                                    
                  

              

      

      

      
        
           

        

        
          2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00131-of-00352.parquet"}]]